ADVERTISEMENT
ADVERTISEMENT
Conceptual gene therapy illustration with 3D multicolored adeno-associated viruses in the foreground and multicolored DNA strands in the background.
Quality Control for Cell and Gene Therapy
An orthogonal method to cell culture speeds up testing for AAV and lentivirus vectors.
Quality Control for Cell and Gene Therapy
Quality Control for Cell and Gene Therapy

An orthogonal method to cell culture speeds up testing for AAV and lentivirus vectors.

An orthogonal method to cell culture speeds up testing for AAV and lentivirus vectors.

lentivirus

iStock
Hijacking Viruses: Optimizing Lentivirus-Based Cell Engineering
The Scientist | Dec 19, 2023 | 1 min read
Filippo Rossignoli discusses the challenges he faced when employing lentiviruses to produce immunotherapies and how he overcame these obstacles.
Learn How Researchers Make the Most of Viral Vectors for Gene Therapy
Viral Vector Platforms for Gene Therapy
The Scientist | Feb 9, 2023 | 1 min read
In both the laboratory and clinic, scientists harness viral genetic transfer capabilities to develop gene therapies that modulate cellular function.
Learn about establishing a Gene Therapy Manufacturing Strategy 
Considerations for Gene Therapy Manufacturing Strategies
Thermo Fisher Scientific | Oct 24, 2022 | 1 min read
Discover tips for setting up and optimizing adeno-associated virus production.
An artistic rendering of blue neurons against a white background
Participant’s Diagnosis Halts Gene Therapy Clinical Trial
Amanda Heidt | Aug 12, 2021 | 3 min read
The FDA pauses the research program on a lentivirus-based treatment for a rare neurological condition after a patient developed a bone marrow disorder that could presage leukemia.
ADVERTISEMENT